These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12619540)

  • 21. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck.
    Margalit DN; Schoenfeld JD; Tishler RB
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1093-106. PubMed ID: 26568550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summary of major radiation fractionation and chemotherapy trials for organ preservation therapy in locally advanced head and neck squamous cell carcinoma.
    Parsons JT; Greene BD
    Pract Radiat Oncol; 2015; 5(5):343-349. PubMed ID: 25920699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
    Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
    Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
    Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials.
    Stuschke M; Thames HD
    Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal dose during radiotherapy: clinical implementation and review of the literature.
    Nuyttens JJ; Prado KL; Jenrette JM; Williams TE
    Cancer Radiother; 2002 Dec; 6(6):352-7. PubMed ID: 12504772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.
    Puc MM; Chrzanowski FA; Tran HS; Liu L; Glicksman AS; Landman C; Slotman GJ
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):337-42. PubMed ID: 10722006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head and neck cancer. Introduction.
    Brizel DM
    Semin Radiat Oncol; 2009 Jan; 19(1):1-2. PubMed ID: 19028338
    [No Abstract]   [Full Text] [Related]  

  • 33. Head and neck cancer: preoperative radiation.
    Arena S
    Pa Med; 1970 Dec; 73(12):35-6. PubMed ID: 5480498
    [No Abstract]   [Full Text] [Related]  

  • 34. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
    Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of patients with stage IV squamous cell carcinoma of the head and neck: a primary radiation therapy experience in 184 cases.
    Ucmakli A
    Otolaryngol Clin North Am; 1980; 13(3):529-32. PubMed ID: 7443241
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.
    Servagi-Vernat S; Differding S; Sterpin E; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
    Acta Oncol; 2015 Jul; 54(7):1008-16. PubMed ID: 25562382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming radioresistance in head and neck squamous cell carcinoma.
    Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
    Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer.
    Tallari RV; Singh OP; Yogi V; Yadav S
    J Cancer Res Ther; 2017; 13(2):224-229. PubMed ID: 28643738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.
    Rosenthal DI; Fuller CD; Peters LJ; Thames HD
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):715-7. PubMed ID: 26104925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.